1. Home
  2. ENR vs RCKT Comparison

ENR vs RCKT Comparison

Compare ENR & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Energizer Holdings Inc.

ENR

Energizer Holdings Inc.

HOLD

Current Price

$17.08

Market Cap

1.3B

Sector

Miscellaneous

ML Signal

HOLD

Logo Rocket Pharmaceuticals Inc.

RCKT

Rocket Pharmaceuticals Inc.

HOLD

Current Price

$4.33

Market Cap

534.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ENR
RCKT
Founded
2015
1999
Country
United States
United States
Employees
N/A
202
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
534.2M
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
ENR
RCKT
Price
$17.08
$4.33
Analyst Decision
Buy
Buy
Analyst Count
7
14
Target Price
$25.00
$29.65
AVG Volume (30 Days)
1.2M
2.9M
Earning Date
05-05-2026
05-07-2026
Dividend Yield
7.18%
N/A
EPS Growth
538.46
N/A
EPS
3.32
N/A
Revenue
$2,952,700,000.00
N/A
Revenue This Year
$4.51
N/A
Revenue Next Year
$1.07
$97.68
P/E Ratio
$5.05
N/A
Revenue Growth
2.28
N/A
52 Week Low
$16.38
$2.19
52 Week High
$30.29
$8.80

Technical Indicators

Market Signals
Indicator
ENR
RCKT
Relative Strength Index (RSI) 32.54 48.79
Support Level $16.76 $4.16
Resistance Level $20.92 $4.51
Average True Range (ATR) 0.71 0.34
MACD -0.12 -0.11
Stochastic Oscillator 15.93 16.93

Price Performance

Historical Comparison
ENR
RCKT

About ENR Energizer Holdings Inc.

Energizer Holdings Inc. manufactures and distributes household batteries, specialty batteries, and lighting products. The company offers batteries using lithium, alkaline, carbon zinc, nickel metal hydride, zinc air, and silver oxide technologies, sold under the Energizer, Rayovac, Varta, and Eveready brands across performance and premium price segments. It also provides auto care products in the appearance, fragrance, performance, and air conditioning recharge categories. Energizer operates through two geographical segments, the United States and International, with the majority of its revenue generated in the United States. It has two product segments: Batteries and Lights and Auto Care, with the Batteries and Lights segment contributing the majority of its revenue.

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.

Share on Social Networks: